Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
FDA Clears Denali Therapeutics Drug As First Brain-Penetrating Biologic For Rare Disease
↗
March 26, 2026
Via
Benzinga
Exposures
Product Safety
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
March 26, 2026
Via
NewMediaWire
Tickers
NMTC
Exposures
Product Safety
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
March 26, 2026
Via
TheNewswire.com
Tickers
NMTC
Exposures
Product Safety
Cognition Therapeutics (NASDAQ:CGTX) Narrows Loss, Eyes Key FDA Meeting on DLB Drug
↗
March 26, 2026
Via
Chartmill
Tickers
CGTX
Exposures
Product Safety
Thermogenic vs Metabolism Boosters Compared: Fat Burning Guide Released
March 25, 2026
Via
Press Release Distribution Service
Exposures
Product Safety
Celcuity Inc. (NASDAQ:CELC) Reports Q4 Earnings Beat and Key FDA Priority Review for Gedatolisib
↗
March 25, 2026
Via
Chartmill
Topics
Earnings
Tickers
CELC
Exposures
Financial
Product Safety
Precigen Inc (NASDAQ:PGEN) Stock Surges on Narrower Loss and Commercial Transition After FDA Approval
↗
March 25, 2026
Via
Chartmill
Tickers
PGEN
Exposures
Product Safety
Kale Health Debunks 5 Gut and Metabolic Wellness Myths Misleading Texans Every Day
March 25, 2026
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now
↗
March 25, 2026
Via
The Motley Fool
Tickers
ARM
AXSM
MDGL
SMMT
Exposures
Product Safety
Precigen (PGEN) Q4 2025 Earnings Call Transcript
↗
March 25, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
PGEN
Exposures
Financial
Product Safety
Why Investors Strapped a Rocket to Corcept Therapeutics Stock on Wednesday
↗
March 25, 2026
Via
The Motley Fool
Tickers
CORT
Exposures
Product Safety
1 Canadian Dividend Stock Up 70% That’s Still the Cream of the TSX Crop
↗
March 25, 2026
Via
The Motley Fool
Topics
Economy
Product Recall
Tickers
SAP
Exposures
Economy
Legal
Product Safety
Denali Jumps, Pulling Regenxbio Higher, On Early FDA Approval
↗
March 25, 2026
Via
Investor's Business Daily
Exposures
Product Safety
Diode Laser vs IPL: Which Hair Removal Machine Is Better for Clinics?
March 25, 2026
Via
AB Newswire
Exposures
Product Safety
What's Behind The Jump In Corcept Therapeutics Stock?
↗
March 25, 2026
Via
Benzinga
Tickers
CORT
Exposures
Product Safety
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
March 25, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
World Trade
Tickers
BLK
LLY
MRK
NVO
NVS
PFE
Exposures
Intellectual Property
Product Safety
Securities Market
Beam Therapeutics Gains On Clinical Update As Gene Therapy Hits Protective Protein Levels
↗
March 25, 2026
Via
Benzinga
Exposures
Product Safety
SOLENO THERAPEUTICS Deadline to Lead in Securities Class Action Lawsuit is May 5, 2026 - Contact Kaplan Fox
March 25, 2026
Via
TheNewswire.com
Topics
Lawsuit
Tickers
SLNO
Exposures
Financial
Legal
Product Safety
SOLENO THERAPEUTICS Deadline to Lead in Securities Class Action Lawsuit is May 5, 2026 - Contact Kaplan Fox
March 25, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
SLNO
Exposures
Financial
Legal
Product Safety
The Pet Economy’s Digital Standard-Bearer: A Deep Dive into Chewy, Inc. (CHWY)
March 25, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Tickers
AMZN
CHWY
WMT
Exposures
COVID-19
Economy
Product Safety
Deadline Approaching for Investors of Corcept Therapeutics, Inc. (CORT) - Contact Kaplan Fox Before April 21, 2026
March 25, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Deadline Approaching for Investors of Corcept Therapeutics, Inc. (CORT) - Contact Kaplan Fox Before April 21, 2026
March 25, 2026
Via
TheNewswire.com
Topics
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Sarepta Therapeutics (SRPT) at a Crossroads: A 2026 Deep Dive into the Future of Genetic Medicine
March 25, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Retirement
Tickers
PFE
SRPT
Exposures
Intellectual Property
Interest Rates
Pension
From Adversity to Visionary Leadership: Randy Anderson’s Journey to Leading MODEXUS
March 25, 2026
Via
Small Business Trendsetters
Topics
Product Recall
Exposures
Legal
Product Safety
Spectral AI (MDAI) Q4 2025 Earnings Transcript
↗
March 25, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Tickers
MDAI
Exposures
Artificial Intelligence
Product Safety
Kaplan Fox is Investigating ImmunityBio, Inc. (IBRX) for Potential Securities Law Violations
March 24, 2026
Via
TheNewswire.com
Tickers
IBRX
Exposures
Product Safety
Kaplan Fox is Investigating ImmunityBio, Inc. (IBRX) for Potential Securities Law Violations
March 24, 2026
Via
NewMediaWire
Tickers
IBRX
Exposures
Product Safety
Harsh Verma on Engineering Beyond the Code: The Future of AI and Cybersecurity
March 24, 2026
Via
Press Release Distribution Service
Topics
Artificial Intelligence
Product Recall
Tickers
PANW
Exposures
Artificial Intelligence
Legal
Product Safety
Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) Seeking Recovery - Contact Kaplan Fox Before Deadline on May 5, 2026
March 24, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
SLNO
Exposures
Financial
Legal
Product Safety
Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) Seeking Recovery - Contact Kaplan Fox Before Deadline on May 5, 2026
March 24, 2026
Via
TheNewswire.com
Topics
Lawsuit
Tickers
SLNO
Exposures
Financial
Legal
Product Safety
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.